Article
Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.
Clinical pharmacology and therapeutics - 1 Aug 2018
Hu Xuejiao, Zhang Mei, Bai Hao, Wu Lijuan, Chen Yanqing, Ding Liu, Zhao Zhenzhen, Peng Wu, Liu Tangyuheng, Song Jiajia, Li Yinyu, Lu Xiaojun, Chen Xuerong, Zhou Yanhong, Ying Binwu
Abstract excerpt
Antituberculosis drug-induced adverse drug reactions (ATD-ADRs) are increasing globally, and it is key to identify candidate ATD-ADRs loci for clinical management. We prospectively enrolled 1,235 highly suspicious tuberculosis (TB) inpatients to investigate the profiles and genetic risk factors of ATD-ADRs in the liver, kidneys, and blood. Overall, 644 subjects were eligible and genotyped for seven polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
